Botox refers to Botulinum Toxins, a protein which is produced by Gram-positive, spore-forming bacterium Clostridium Botulinum. Botulinum toxin is a potent neurotoxin protein that inhibits signal conduction to the neuromuscular endplate. The toxin acts directly on the neuromuscular endplate and other cholinergic synapses where it inhibits the release of the neurotransmitter acetylcholine, leading to muscular paralysis of the affected fibre and loss of target organ function. Limited and diluted amounts of botulinum toxin are used for treating several therapeutic indications such as cervical dystonia, lazy eye, muscle contractures, hyperhidrosis, chronic migraine and bladder dysfunction among others. There are seven serologically distinct types of botulinum toxin such as A, B, C1, D, E, F, and G. Botulinum toxin types A and B are commonly used in medical preparations for the treatment of muscle spasms.
Market Industry Reports (MIR) has published a new report titled “Botox Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global botox market is estimated to be over US$ 4800 million in 2019. It is anticipated to grow at 7.5% CAGR from 2019 to 2030.
Major Key Players of the Botox Market are:
Allergan, Ipsen Group, Medytox, Merz Pharma, HUGEL, US WorldMeds, Galderma Laboratories, L.P., Revance Therapeutics, Inc, Eisai Co., Ltd. and DAEWOONG CO.LTD among others.
Allergan, Ipsen Group, Medytox, Merz Pharma, HUGEL, US WorldMeds, Galderma Laboratories, L.P., Revance Therapeutics, Inc, Eisai Co., Ltd. and DAEWOONG CO.LTD among others.
No comments:
Post a Comment